Prostate Cancer: Stages, Diagnosis, and Treatment Options
Quick Answer
Prostate cancer is the most common non-skin cancer in men. When detected early, the 5-year survival rate is nearly 100%.
Summary
A comprehensive overview of prostate cancer including risk factors, stages, diagnostic methods, and modern treatment options from active surveillance to surgery.
Key Takeaways
- Prostate cancer is highly treatable when detected early
- Risk factors include age, family history, and ethnicity
- Gleason Score and TNM staging guide treatment decisions
- Treatment options range from active surveillance to radiation to surgery
- Regular screening is essential for early detection
Overview
Prostate cancer develops in the prostate gland and is the most common cancer among men. The majority of prostate cancers grow slowly and may not need immediate treatment.
Risk Factors
- Age: Risk increases significantly after age 50
- Family History: Having a father or brother with prostate cancer doubles your risk
- Ethnicity: African American men have the highest incidence
- Diet: High-fat diets may increase risk
Diagnosis
PSA Testing
Blood test measuring prostate-specific antigen levels.
Digital Rectal Exam (DRE)
Physical examination of the prostate.
MRI
Multiparametric MRI can identify suspicious areas.
Biopsy
Tissue samples examined under a microscope.
Staging
- Stage I: Small, slow-growing, confined to prostate
- Stage II: Larger, still within prostate
- Stage III: Extends beyond prostate
- Stage IV: Spread to lymph nodes or distant organs
Treatment Options
Active Surveillance
Monitoring low-risk cancers without immediate treatment.
Surgery
Radical prostatectomy — removal of the entire prostate.
Radiation Therapy
External beam radiation or brachytherapy.
Hormone Therapy
Reducing testosterone levels to slow cancer growth.
Chemotherapy
For advanced or hormone-resistant cancer.
Dr. Priyadarshi Ranjan
Consultant Urologist & Prostate Health Specialist
Globally recognised urologist and pioneer in minimally invasive prostate care.
- MBBS, MS, MCh (Urology)
- Pioneer in Minimally Invasive Prostate Care
- Internationally Recognised Urologist
Have a question about your prostate health?
Get personalised, evidence-based guidance from a globally recognised urologist and pioneer in minimally invasive prostate care.
Key Facts
- 1 in 8 men will be diagnosed with prostate cancer in their lifetime
- The 5-year survival rate for localized prostate cancer is 99%
- Prostate cancer is the second leading cause of cancer death in American men
- Average age of diagnosis is 66 years
Expert Opinion
The landscape of prostate cancer treatment has evolved dramatically. With advances in MRI-guided biopsy, robotic surgery, and precision radiation, we can now offer more targeted treatments with fewer side effects than ever before.
Frequently Asked Questions
References
- American Cancer Society. Cancer Facts & Figures 2024.
- National Comprehensive Cancer Network. NCCN Guidelines for Prostate Cancer.
- Mottet N, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. European Urology. 2021.
Ready to talk to a specialist?
Connect with Dr. Priyadarshi Ranjan for personalised, expert prostate care.